ABINGDON HEALTH PLC Logo

ABINGDON HEALTH PLC

A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.

ABDX | IL

Overview

Corporate Details

ISIN(s):
GB00BLB79S77 (+2 more)
LEI:
213800XFI4WV3FBILO20
Country:
United Kingdom
Address:
YORK BIOTECH CAMPUS, YO41 1LZ YORK
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) specializing in lateral flow rapid tests. The company provides comprehensive, end-to-end services supporting clients from initial concept through to commercial success. Core offerings include assay development, scale-up, technical transfer, high-volume manufacturing, regulatory consultancy, and commercialization support. The company serves a diverse range of sectors, including clinical diagnostics, animal health, and plant health. In addition to its contract services, Abingdon Health also develops, manufactures, and distributes its own portfolio of branded lateral flow products to a global network of consumers, retailers, and distributors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-04 08:45
Vesting and Award of Options under LTIP
English 87.4 KB
2025-12-02 16:20
Holding(s) in Company
English 119.0 KB
2025-11-14 15:10
Notice of AGM & Publication of 2025 Annual Report
English 15.7 KB
2025-11-11 08:20
Final Results
English 305.0 KB
2025-11-10 08:10
c.US$2m multiplex diagnostic test contract win
English 17.6 KB
2025-11-06 08:30
Launch of seaweed-based lateral flow housings
English 22.3 KB
2025-11-04 18:10
Holding(s) in Company
English 50.5 KB
2025-11-04 08:25
Holding(s) in Company
English 52.1 KB
2025-11-03 08:30
Notice of Results
English 17.3 KB
2025-10-30 10:43
Result of Meeting and TVR
English 61.1 KB
2025-10-17 08:00
Result of Retail Offer
English 24.5 KB
2025-10-14 08:58
Launch of Retail Offer
English 50.1 KB
2025-10-14 08:47
Result of Placing and Notice of GM
English 30.1 KB
2025-10-13 18:04
Proposed Placing and Retail Offer
English 214.5 KB
2025-08-14 19:01
Director/PDMR Shareholding
English 26.1 KB

Automate Your Workflow. Get a real-time feed of all ABINGDON HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ABINGDON HEALTH PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ABINGDON HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Cognition Inc. Logo
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
United States of America
ACOG
Alpha Teknova, Inc. Logo
Manufactures critical reagents for biopharma, scaling from research to GMP manufacturing.
United States of America
TKNO
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Altimmune, Inc. Logo
Developing novel peptide therapeutics for obesity, liver, and cardiometabolic diseases.
United States of America
ALT
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.